JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB180578

Anti-MGAT1 antibody [EPR14247]

5

(5 Reviews)

|

(11 Publications)

Rabbit Recombinant Monoclonal MGAT1 antibody. Suitable for WB and reacts with Human samples. Cited in 11 publications.

View Alternative Names

GGNT1, GLCT1, GLYT1, MGAT, MGAT1, N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I, GNT-I, GlcNAc-T I

3 Images
Western blot - Anti-MGAT1 antibody [EPR14247] (AB180578)
  • WB

Supplier Data

Western blot - Anti-MGAT1 antibody [EPR14247] (AB180578)

All lanes:

Western blot - Anti-MGAT1 antibody [EPR14247] (ab180578) at 1/10000 dilution

All lanes:

HeLa cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution

Predicted band size: 51 kDa

false

Western blot - Anti-MGAT1 antibody [EPR14247] (AB180578)
  • WB

Supplier Data

Western blot - Anti-MGAT1 antibody [EPR14247] (AB180578)

All lanes:

Western blot - Anti-MGAT1 antibody [EPR14247] (ab180578) at 1/2000 dilution

All lanes:

293 cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit igG, (H+L), Peroxidase conjugate at 1/1000 dilution

Predicted band size: 51 kDa

false

Western blot - Anti-MGAT1 antibody [EPR14247] (AB180578)
  • WB

CiteAb

Western blot - Anti-MGAT1 antibody [EPR14247] (AB180578)

MGAT1 western blot using anti-MGAT1 antibody [EPR14247] ab180578. Publication image and figure legend from Fisher, P., Spencer, H., et al., 2019, Cell Rep, PubMed 31018136.

ab180578 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab180578 please see the product overview.

Predicting Organizational Changes in Trafficking Defective Cell Lines(A and B) Observed and simulated glycan profiles of Cog4KD HeLa cell lines (A) and Cog4KO HEK293T cell lines (B). Error bars for glycan profiling are SEM for n = 3.(C) Total effective enzymatic rate changes predicted by the model following fitting as a result of Cog4 perturbation. The x axis is on a log scale. Error bars for total effective enzymatic rates and distributions are SD for n = 20 (Cog4KD HeLa) and n = 21 (Cog4KO HEK293T) individual fitting procedures.(D) Western blot analysis of endogenous MGAT1, GalT, and FUT8 and quantification normalized to WT HEK293T. Error bars for western blot quantification are SD for n = 3. ns, not significant; *p < 0.05 for a Student's t test.(E) Predicted relative distribution of MAN1 following the fitting of WT and Cog4KD HeLa glycan profiles.(F) Predicted relative distributions of selected enzymes in WT and Cog4KO HEK293T cells in each cisterna normalized to the total predicted effective enzymatic rate for each enzyme for each cell line.(G) Airyscan confocal microscopy of GM130 and exogenous GalT-YFP in nocodazole-treated WT and Cog4KO HEK293T cell lines.(H) Pearson's correlation coefficient for WT and Cog4KO HEK293T cells. Pearson's correlation coefficients were calculated for each Golgi stack, and error bars are SD for n = 4 cells with 151 (WT) and 131 (Cog4KO) stacks. ***p < 0.001 for a Student's t test.See also Figures S3 and S6 and Table S3.

false

  • Carrier free

    Anti-MGAT1 antibody [EPR14247] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR14247

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
Preservative: 0.01% Sodium azide Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MGAT1 also known as mannosyl (α-13-)-glycoprotein β-12-N-acetylglucosaminyltransferase is an enzyme with a molecular mass of approximately 51 kDa. It is a critical component of the N-glycosylation process in eukaryotic cells. This protein resides primarily in the Golgi apparatus where it acts as a glycosyltransferase enzyme. MGAT1 catalyzes the transfer of N-acetylglucosamine to the mannose residues on the glycan chain which is an important step in forming complex N-glycans. This modification impacts several cellular functions.
Biological function summary

MGAT1 plays an essential role in protein folding stability and function by modifying N-glycans attached to nascent proteins. The enzyme acts as part of a complex that includes other enzymes like MGAT2 MGAT3 and MGAT5 in the glycan biosynthesis pathway. MGAT1's activity significantly influences cell-cell communication signaling and immune responses. Its function enhances the diversity and biological roles of glycoproteins within cells impacting various physiological processes.

Pathways

MGAT1 is a significant player in the protein glycosylation and folding pathways. It interacts with proteins like MGAT2 and galectin-3 indicating its involvement in broader metabolic processes. N-glycan biosynthesis pathway is its primary pathway where it contributes by enabling the elongation and branching of N-glycan structures. This glycosylation process affects cellular processes such as signal transduction and protein trafficking through downstream effects on glycoproteins.

MGAT1 has implications in congenital disorders of glycosylation and cancer. Abnormal MGAT1 activity leads to improper glycosylation causing congenital disorders that affect multiple systems including nervous and digestive systems. In cancer MGAT1-linked glycan alterations on surface proteins contribute to tumor progression and metastasis. Disrupted interactions with proteins like MGAT5 can increase cell surface glycoprotein complexity promoting cancer cell survival and immune evasion.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans.
See full target information MGAT1

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Traffic (Copenhagen, Denmark) 24:52-75 PubMed36468177

2022

Acute COG complex inactivation unveiled its immediate impact on Golgi and illuminated the nature of intra-Golgi recycling vesicles.

Applications

Unspecified application

Species

Unspecified reactive species

Farhana Taher Sumya,Irina D Pokrovskaya,Zinia D'Souza,Vladimir V Lupashin

Cell reports 41:111679 PubMed36417860

2022

Mitotic phosphorylation inhibits the Golgi mannosidase MAN1A1.

Applications

Unspecified application

Species

Unspecified reactive species

Shijiao Huang,Yoshimi Haga,Jie Li,Jianchao Zhang,Hye Kyong Kweon,Junichi Seino,Hiroto Hirayama,Morihisa Fujita,Kelley W Moremen,Philip Andrews,Tadashi Suzuki,Yanzhuang Wang

Molecular biology of the cell 32:1594-1610 PubMed34161137

2021

The Golgi-associated retrograde protein (GARP) complex plays an essential role in the maintenance of the Golgi glycosylation machinery.

Applications

Unspecified application

Species

Unspecified reactive species

Amrita Khakurel,Tetyana Kudlyk,Juan S Bonifacino,Vladimir V Lupashin

PLoS pathogens 17:e1009244 PubMed33539469

2021

N-Glycans and sulfated glycosaminoglycans contribute to the action of diverse Tc toxins on mammalian cells.

Applications

Unspecified application

Species

Unspecified reactive species

Nan Song,Lihong Chen,Xingmei Ren,Nicholas R Waterfield,Jian Yang,Guowei Yang

Frontiers in cell and developmental biology 8:212 PubMed32300591

2020

Transgenic Rescue of Spermatogenesis in Males With Deleted in Germ Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Barnali Biswas,Frank Batista,Ayodele Akintayo,Jennifer Aguilan,Pamela Stanley

Cells 8: PubMed31847122

2019

Post-ER Stress Biogenesis of Golgi Is Governed by Giantin.

Applications

Unspecified application

Species

Unspecified reactive species

Cole P Frisbie,Alexander Y Lushnikov,Alexey V Krasnoslobodtsev,Jean-Jack M Riethoven,Jennifer L Clarke,Elena I Stepchenkova,Armen Petrosyan

Frontiers in cell and developmental biology 7:118 PubMed31334232

2019

Defects in COG-Mediated Golgi Trafficking Alter Endo-Lysosomal System in Human Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Zinia D'Souza,Jessica Bailey Blackburn,Tetyana Kudlyk,Irina D Pokrovskaya,Vladimir V Lupashin

Cell reports 27:1231-1243.e6 PubMed31018136

2019

Modeling Glycan Processing Reveals Golgi-Enzyme Homeostasis upon Trafficking Defects and Cellular Differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Peter Fisher,Hannah Spencer,Jane Thomas-Oates,A Jamie Wood,Daniel Ungar

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33:2823-2835 PubMed30307765

2018

N-acetylglucosaminyltransferase-I as a novel regulator of epithelial-mesenchymal transition.

Applications

Unspecified application

Species

Unspecified reactive species

Guowei Zhang,Tomoya Isaji,Zhiwei Xu,Xu Lu,Tomohiko Fukuda,Jianguo Gu

Journal of cell science 130:3234-3247 PubMed28775154

2017

A genome-wide CRISPR screen reconciles the role of N-linked glycosylation in galectin-3 transport to the cell surface.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah E Stewart,Sam A Menzies,Stephanie J Popa,Natalia Savinykh,Anna Petrunkina Harrison,Paul J Lehner,Kevin Moreau
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com